14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SBBP
Delisted

Strongbridge Biopharma plc Stock Predictions

$2.00
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

SBBP Predictions History

3 years ago
JS predicted that SBBP for 2021-01-04 is going $2.36 (-4.07%)

3 years ago
Daniel87 predicted that SBBP for 2021-01-04 is going

Rank:

3 years ago
JS predicted that SBBP for 2020-11-30 is going $2.67 (-3.61%)

3 years ago
Alan predicted that SBBP for 2020-11-30 is going $2.90 (5.07%)

3 years ago
JS predicted that SBBP for 2020-06-22 is going $4.22 (-4.09%)

3 years ago
Alan predicted that SBBP for 2020-06-22 is going $4.22 (-4.09%)

5 years ago
NameNotImportant predicted that SBBP for 2019-05-03 is going $3.57 (2.88%)

5 years ago
NameNotImportant predicted that SBBP for 2019-05-02 is going $4.28 (16.94%)

5 years ago
JS predicted that SBBP for 2019-03-12 is going $5.45 (1.87%)

5 years ago
Sergiu predicted that SBBP for 2019-03-12 is going $5.65 (5.61%)

Rank:
Click to get the best stock tips daily for free!

About Strongbridge Biopharma plc

Strongbridge Biopharma plc Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company’s lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing’s syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to ... SBBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT